News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

S. Meas

Articles by S. Meas

69 The Importance of Tri-Modality Therapy for De Novo Stage IV Invasive Lobular Carcinoma (ILC) Presenting With Bone-Only Metastases

ByAttilla Soran,Berk Goktepe,Berkay Demirors,Serdar Ozbas,Efe Sezgin,Jamila Al-Azhri,Shruti Zaveri,S. Meas,Anthony Lucci, MD,Priscilla F. Mcauliffe, MD, PhD

April 21st 2024

Latest Updated Articles

Trending on CancerNetwork

Durvalumab/Carboplatin/Etoposide Prove Tolerable in ES-SCLC

Tarlatamab Earns Traditional FDA Approval in ES-SCLC

FDA Approves Sevabertinib in Non-Squamous NSCLC

EU Approves Subcutaneous Pembrolizumab in All Approved Indications

Elucidating Emergent Neoadjuvant Strategies For Stage I-III Lung Cancers

© 2025 MJH Life Sciences^®

All rights reserved.